Delivery Order SPE2DR25D3009-SPE2DR26FWHD8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,241.90 to AmerisourceBergen Drug Corp for the supply of OxyContin ER 10 mg tablets (100-count packages). The contract, which was competitively awarded with no set-aside designation, carries a firm fixed price structure and an ultimate completion date of November 4, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) valued at $2,108.35 under a firm fixed-price contract type. The award was made on December 19, 2025, with an ultimate completion date of December 22, 2025, and represents a non-competitive, non-set-aside procurement. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and headquarters. This delivery...
- The Defense Logistics Agency awarded a $2,315.52 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on November 12, 2025, with completion targeted for November 13, 2025. This firm fixed-price contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract is non-set-aside and was competitively awarded, reflecting...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,438.70 for OxyContin ER 20 mg tablets (100-count) on December 10, 2025, with a completion date of December 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) valued at $1,052.59, with an ultimate completion date of August 26, 2025. This competitive, non-set-aside contract was awarded on a firm fixed-price basis under a delivery order contract type. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,065.61 to AmerisourceBergen Drug Corp for 100 tablets of OxyContin ER 20 mg, with an ultimate completion date of October 29, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen Drug Corp's larger federal contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,423.36 for OxyContin ER 10 mg tablets (100-count units) with a completion date of December 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $10,091.11 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,932.66 to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count bottles) with an ultimate completion date of July 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order is issued under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) with a ceiling value of $1,768.88. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is executed under AmerisourceBergen's broader Indefinite...
- SPE2DR25D3009Indefinite Delivery Contract
- SPE2DR25D3009-SPE2DR26FWHD8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,755.70 to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100 count) on January 7, 2026, with completion scheduled for January 8, 2026. This competitively awarded, firm fixed-price delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, operates as a comprehensive global pharmaceutical support vehicle through December 31, 2031, enabling the delivery of a broad spectrum of pharmaceutical products and medical supplies to support military healthcare systems worldwide. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor in the federal pharmaceutical supply chain, with the performance location of this delivery order also located in Conshohocken. The company's extensive contract portfolio with DLA demonstrates its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order represents routine pharmaceutical resupply activities supporting military medical treatment facilities and veteran healthcare programs under DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 1/6/26 |